Case Study •
Glioblastoma Multiforme
A 42 year old male requested telemedicine consultation for treatment of glioblastoma. He developed unremitting headaches was diagnosed with a grade...
|
INTEGRATED HEALTHCARE PRACTITIONERS - Cover story on Medicor Cancer Centre IHP Magazine featured Medicor Cancer Centre and Dr. Akbar Khan in the September issue of ihpmagazine.com. Click here to read the complete feature.
MEDICOR CASE REPORT - First publication on Use of Oral DCA Medicor's Medical Director is pleased to announce his first publication in a peer-reviewed American medical journal, The Journal of Palliative Medicine. It is entitled "Use of Oral Dicholoracetate for Palliation of Leg Pain Arising from Metastatic Poorly Differentiated Carcinoma: A Case Report". The publication is "open access" and can be downloaded by clicking here on the publisher's PDF. and the publisher's link. It is Medline indexed and will be searchable via PubMed shortly. We hope you enjoy reading it. Comments are welcome. MEDICOR's Comments - Latest DCA Research Shows Favorable Results in Glioblastoma Since the first paper on DCA as a potential cancer treatment was published in Cancer Cell in January 2007, there has been a great interest in further DCA research in humans.  Case Study • A 59 year old female presented to us for treatment of metastatic ovarian carcinoma. The patient was diagnosed 4 years previously when she felt an axillary mass... News Article • May 25th, 2009 Television interview with 2 patients in Norway LDN Research Trust Cancer Article • The Role of Low Dose Naltrexone (LDN) in Cancer Treatment. Vesteralen Online Article • Medisinen er for billig - Legen som behandler den kreftsyke Geir Arne Ovaldsen mener årsaken til at medisinen ikke godkjennes, er at den er for billig. |
Medicor Cancer has moved upstairs within the same building. Stay tuned as Medicor Cancer gets ready to launch the new website.